{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:51:56Z","timestamp":1791129116708,"version":"4.1.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["SRF-DIRECT (113-5228-11095\/2K23\/1)"],"award-info":[{"award-number":["SRF-DIRECT (113-5228-11095\/2K23\/1)"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anusandhan National Research Foundation India","award":["ANRF\/PAIR\/2025\/000029\/PAIR dated 20 September 2025"],"award-info":[{"award-number":["ANRF\/PAIR\/2025\/000029\/PAIR dated 20 September 2025"]}],"id":[{"id":"https:\/\/ror.org\/00d4e4338","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Anusandhan National Research Foundation, India","award":["EEQ\/2020\/000188"],"award-info":[{"award-number":["EEQ\/2020\/000188"]}],"id":[{"id":"https:\/\/ror.org\/00d4e4338","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11585-4","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T13:47:04Z","timestamp":1779544024000},"page":"8355-8376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the renoprotective potential of Beta vulgaris in diabetic nephropathy: an integrated network pharmacology, molecular docking and dynamics simulation study"],"prefix":"10.1007","volume":"30","author":[{"given":"Abhishek","family":"Sehrawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Thareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder Singh","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"5","key":"11585_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4239\/wjd.v10.i5.269","volume":"10","author":"J Kopel","year":"2019","unstructured":"Kopel J, Pena-Hernandez C, Nugent K (2019) Evolving spectrum of diabetic nephropathy. World J Diabetes 10(5):269\u2013279","journal-title":"World J Diabetes"},{"issue":"5","key":"11585_CR2","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1111\/jcmm.14237","volume":"23","author":"J Shang","year":"2019","unstructured":"Shang J et al (2019) Chemerin\/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathy. J Cell Mol Med 23(5):3417\u20133428","journal-title":"J Cell Mol Med"},{"issue":"1","key":"11585_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12933-020-01159-5","volume":"19","author":"W Ling","year":"2020","unstructured":"Ling W et al (2020) Global trend of diabetes mortality attributed to vascular complications, 2000\u20132016. Cardiovasc Diabetol 19(1):182","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"11585_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11892-018-0980-x","volume":"18","author":"OK Duru","year":"2018","unstructured":"Duru OK et al (2018) The landscape of diabetic kidney disease in the United States. Curr Diab Rep 18(3):14","journal-title":"Curr Diab Rep"},{"issue":"6","key":"11585_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2337\/db08-0061","volume":"57","author":"Y Qian","year":"2008","unstructured":"Qian Y et al (2008) From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57(6):1439\u20131445","journal-title":"Diabetes"},{"issue":"10","key":"11585_CR6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1007\/BF02374500","volume":"36","author":"R Osterby","year":"1993","unstructured":"Osterby R et al (1993) Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36(10):1064\u20131070","journal-title":"Diabetologia"},{"issue":"4","key":"11585_CR7","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1172\/JCI111523","volume":"74","author":"SM Mauer","year":"1984","unstructured":"Mauer SM et al (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74(4):1143\u20131155","journal-title":"J Clin Invest"},{"key":"11585_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","volume":"184","author":"JS Bhatti","year":"2022","unstructured":"Bhatti JS et al (2022) Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radic Biol Med 184:114\u2013134","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"11585_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4161\/oxim.3.2.11148","volume":"3","author":"S Yamagishi","year":"2010","unstructured":"Yamagishi S, Matsui T (2010) Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev 3(2):101\u2013108","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"11585_CR10","doi-asserted-by":"publisher","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","volume":"312","author":"R Pichler","year":"2017","unstructured":"Pichler R et al (2017) Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Renal Physiol 312(4):F716\u2013F731","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"11585_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000447434","volume":"133","author":"R Hojs","year":"2016","unstructured":"Hojs R et al (2016) Markers of inflammation and oxidative stress in the development and progression of renal disease in diabetic patients. Nephron 133(3):159\u2013162","journal-title":"Nephron"},{"key":"11585_CR12","unstructured":"Agarwal, R., Pathogenesis of Diabetic Nephropathy, in Chronic Kidney Disease and Type 2 Diabetes. 2021: Arlington (VA) for Vifor and on advisory boards for AstraZeneca, Boehringer Ingelheim, Janssen, Merck, Novo Nordisk, and Vifor. R.A. has received consulting fees from Akebia, AstraZeneca, Bayer, Boehringer Ingelheim, Chinook, Diamedica, Merck, Reata, Relypsa, and Sanofi and has received royalties from UpToDate. P.R.'s institution has received honoraria from his teaching and consultancy activities from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, Merck, Merck, Sharp, & Dohme, Mundipharma, Novo Nordisk, Sanofi, and Vifor. J.B. serves as a consultant for Abbott, Adrenomed, Amgen, Array, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squib, CVRx, G3 Pharmaceutical, Impulse Dynamics, Innolife, Janssen, LivaNova, Luitpold, Medtronic, Merck, Novartis, Novo Nordisk, Relypsa, Roche, V-Wave Limited, and Vifor. K.C.N. has been a consultant to Atlantis Health Care, served on an advisory board for ESRD Network 3, and been a board member of the Forum of ESRD Networks. S.D.-J. has received research grants from the National Institutes of Health, and his institution has received funding for clinical trials in which he was an investigator from AstraZeneca, Boehringer Ingelheim, and Novo Nordisk; he has served as a consultant or advisory board member for AstraZeneca, Bayer, Boehringer Ingelheim, Janssen, Merck, and Sanofi; and he is a stock shareholder in Aerami Therapeutics and Jana Care. G.L.B. has been a consultant to Alnylam, AstraZeneca, Bayer, Ionis, KBP Biosciences, Merck, and Vifor and has served on clinical trial steering committees for Bayer, Novo Nordisk, and Vascular Dynamics. No other potential conflicts of interest relevant to this compendium were reported. p. 2\u20137."},{"issue":"2","key":"11585_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-2007-949721","volume":"115","author":"JM Forbes","year":"2007","unstructured":"Forbes JM, Fukami K, Cooper ME (2007) Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes 115(2):69\u201384","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"11585_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0002-9343(82)90490-9","volume":"72","author":"TH Hostetter","year":"1982","unstructured":"Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72(3):375\u2013380","journal-title":"Am J Med"},{"issue":"24","key":"11585_CR15","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V et al (2019) Canagliflozin and renal outcomes in Type 2 Diabetes and nephropathy. N Engl J Med 380(24):2295\u20132306","journal-title":"N Engl J Med"},{"issue":"2","key":"11585_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ndt\/gfy407","volume":"34","author":"P Sarafidis","year":"2019","unstructured":"Sarafidis P et al (2019) SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrol Dial Transplant 34(2):208\u2013230","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"11585_CR17","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/dci18-0033","volume":"41","author":"MJ Davies","year":"2018","unstructured":"Davies MJ et al (2018) Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 41(12):2669\u20132701","journal-title":"Diabetes Care"},{"issue":"2","key":"11585_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1590\/S0100-879X2000000200004","volume":"33","author":"JB Calixto","year":"2000","unstructured":"Calixto JB (2000) Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 33(2):179\u2013189","journal-title":"Braz J Med Biol Res"},{"key":"11585_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.niox.2017.01.011","volume":"64","author":"S Kemmner","year":"2017","unstructured":"Kemmner S et al (2017) Dietary nitrate load lowers blood pressure and renal resistive index in patients with chronic kidney disease: a pilot study. Nitric Oxide 64:7\u201315","journal-title":"Nitric Oxide"},{"issue":"3","key":"11585_CR20","doi-asserted-by":"publisher","first-page":"G356","DOI":"10.1152\/ajpgi.00203.2016","volume":"311","author":"AI Shepherd","year":"2016","unstructured":"Shepherd AI et al (2016) Effect of nitrate supplementation on hepatic blood flow and glucose homeostasis: a double-blind, placebo-controlled, randomized control trial. Am J Physiol Gastrointest Liver Physiol 311(3):G356\u2013G364","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"11585_CR21","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/ptr.5491","volume":"29","author":"L Nowacki","year":"2015","unstructured":"Nowacki L et al (2015) Betanin-enriched red beetroot (Beta vulgaris L.) extract induces apoptosis and autophagic cell death in MCF-7 cells. Phytother Res 29(12):1964\u20131973","journal-title":"Phytother Res"},{"issue":"2","key":"11585_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116546","volume":"10","author":"A Ul Kabir","year":"2015","unstructured":"Ul Kabir A et al (2015) Aqueous fraction of Beta vulgaris ameliorates hyperglycemia in diabetic mice due to enhanced glucose stimulated insulin secretion, mediated by acetylcholine and GLP-1, and elevated glucose uptake via increased membrane bound GLUT4 transporters. PLoS ONE 10(2):e0116546","journal-title":"PLoS ONE"},{"issue":"6","key":"11585_CR23","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.fct.2012.03.062","volume":"50","author":"V Krajka-Kuzniak","year":"2012","unstructured":"Krajka-Kuzniak V et al (2012) Beetroot juice protects against N-nitrosodiethylamine-induced liver injury in rats. Food Chem Toxicol 50(6):2027\u20132033","journal-title":"Food Chem Toxicol"},{"key":"11585_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.foodchem.2018.08.022","volume":"272","author":"N Chhikara","year":"2019","unstructured":"Chhikara N et al (2019) Bioactive compounds of beetroot and utilization in food processing industry: a critical review. Food Chem 272:192\u2013200","journal-title":"Food Chem"},{"issue":"1","key":"11585_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2013.09.001","volume":"231","author":"PJ Joris","year":"2013","unstructured":"Joris PJ, Mensink RP (2013) Beetroot juice improves in overweight and slightly obese men postprandial endothelial function after consumption of a mixed meal. Atherosclerosis 231(1):78\u201383","journal-title":"Atherosclerosis"},{"key":"11585_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.biopha.2017.01.146","volume":"88","author":"I Dhananjayan","year":"2017","unstructured":"Dhananjayan I et al (2017) Ameliorating effect of betanin, a natural chromoalkaloid by modulating hepatic carbohydrate metabolic enzyme activities and glycogen content in streptozotocin - nicotinamide induced experimental rats. Biomed Pharmacother 88:1069\u20131079","journal-title":"Biomed Pharmacother"},{"key":"11585_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/983952","volume":"2014","author":"AA El Gamal","year":"2014","unstructured":"El Gamal AA et al (2014) Beetroot (Beta vulgaris L.) extract ameliorates gentamicin-induced nephrotoxicity associated oxidative stress, inflammation, and apoptosis in rodent model. Mediators Inflamm 2014:p. 983952","journal-title":"Mediators Inflamm"},{"key":"11585_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2013.01.024","volume":"60","author":"M Gilchrist","year":"2013","unstructured":"Gilchrist M et al (2013) Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radic Biol Med 60:89\u201397","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"11585_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/10715762.2011.641157","volume":"46","author":"Y Sakihama","year":"2012","unstructured":"Sakihama Y et al (2012) Beetroot betalain inhibits peroxynitrite-mediated tyrosine nitration and DNA strand cleavage. Free Radic Res 46(1):93\u201399","journal-title":"Free Radic Res"},{"issue":"6","key":"11585_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ptr.3649","volume":"26","author":"M Zielinska-Przyjemska","year":"2012","unstructured":"Zielinska-Przyjemska M et al (2012) The beetroot component betanin modulates ROS production, DNA damage and apoptosis in human polymorphonuclear neutrophils. Phytother Res 26(6):845\u2013852","journal-title":"Phytother Res"},{"key":"11585_CR31","doi-asserted-by":"crossref","unstructured":"Noor, F., et al., Network Pharmacology Approach for Medicinal Plants: Review and Assessment. Pharmaceuticals (Basel), 2022. 15(5).","DOI":"10.3390\/ph15050572"},{"issue":"6","key":"11585_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO (2018) Molecular dynamics simulation for all. Neuron 99(6):1129\u20131143","journal-title":"Neuron"},{"issue":"9","key":"11585_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nsb0902-646","volume":"9","author":"M Karplus","year":"2002","unstructured":"Karplus M, McCammon JA (2002) Molecular dynamics simulations of biomolecules. Nat Struct Biol 9(9):646\u2013652","journal-title":"Nat Struct Biol"},{"issue":"1","key":"11585_CR34","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1038\/s41598-018-22631-z","volume":"8","author":"K Mohanraj","year":"2018","unstructured":"Mohanraj K et al (2018) IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics. Sci Rep 8(1):4329","journal-title":"Sci Rep"},{"issue":"9","key":"11585_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/17460441.2016.1216967","volume":"11","author":"S Kim","year":"2016","unstructured":"Kim S (2016) Getting the most out of PubChem for virtual screening. Expert Opin Drug Discov 11(9):843\u2013855","journal-title":"Expert Opin Drug Discov"},{"key":"11585_CR36","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c03068","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Pan Y, Wang K (2025) Exploring the antitumor mechanisms of Bai-Hua-She-She-Cao and Ban-Zhi-Lian against head and neck squamous cell carcinoma: a study on natural anticancer therapeutics. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.5c03068","journal-title":"ACS Omega"},{"key":"11585_CR37","doi-asserted-by":"publisher","first-page":"2282351","DOI":"10.1155\/2022\/2282351","volume":"2022","author":"J Xie","year":"2022","unstructured":"Xie J et al (2022) Identifying and Targeting Prediction of the PI3K-AKT Signaling Pathway in Drug-Induced Thrombocytopenia in Infected Patients Receiving Linezolid Therapy: A Network Pharmacology-Based Analysis. J Healthc Eng 2022:2282351","journal-title":"J Healthc Eng"},{"issue":"10","key":"11585_CR38","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2174\/1386207325666220523151119","volume":"25","author":"Z Zhang","year":"2022","unstructured":"Zhang Z et al (2022) Integration of network pharmacology and molecular docking technology reveals the mechanism of the therapeutic effect of Xixin Decoction on Alzheimer\u2019s Disease. Comb Chem High Throughput Screen 25(10):1785\u20131804","journal-title":"Comb Chem High Throughput Screen"},{"key":"11585_CR39","doi-asserted-by":"publisher","first-page":"1 30 1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G et al (2016) The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 54:1 30 1-1 30 33","journal-title":"Curr Protoc Bioinformatics"},{"key":"11585_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110409","volume":"121","author":"S Wang","year":"2023","unstructured":"Wang S et al (2023) Identification of several inflammation-related genes based on bioinformatics and experiments. Int Immunopharmacol 121:110409","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"11585_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle H et al (2015) InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics 16(1):169","journal-title":"BMC Bioinformatics"},{"issue":"14","key":"11585_CR42","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1093\/emboj\/cdg359","volume":"22","author":"IM Nooren","year":"2003","unstructured":"Nooren IM, Thornton JM (2003) Diversity of protein-protein interactions. EMBO J 22(14):3486\u20133492","journal-title":"EMBO J"},{"issue":"D1","key":"11585_CR43","doi-asserted-by":"publisher","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","volume":"53","author":"D Szklarczyk","year":"2025","unstructured":"Szklarczyk D et al (2025) The STRING database in 2025: protein networks with directionality of regulation. Nucleic Acids Res 53(D1):D730\u2013D737","journal-title":"Nucleic Acids Res"},{"key":"11585_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106840","volume":"140","author":"Z Sun","year":"2023","unstructured":"Sun Z et al (2023) Mechanisms of polydatin against spinal cord ischemia-reperfusion injury based on network pharmacology, molecular docking and molecular dynamics simulation. Bioorg Chem 140:106840","journal-title":"Bioorg Chem"},{"key":"11585_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105454","volume":"145","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) Mechanisms underlying the therapeutic effects of Qingfeiyin in treating acute lung injury based on GEO datasets, network pharmacology and molecular docking. Comput Biol Med 145:105454","journal-title":"Comput Biol Med"},{"key":"11585_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107863","volume":"169","author":"X Yu","year":"2024","unstructured":"Yu X et al (2024) Analyzing the molecular mechanism of Xuefuzhuyu Decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking. Comput Biol Med 169:107863","journal-title":"Comput Biol Med"},{"key":"11585_CR47","unstructured":"Gene Ontology, C., et al., The Gene Ontology knowledgebase in 2023. Genetics, 2023. 224(1)."},{"issue":"D1","key":"11585_CR48","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M et al (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45(D1):D353\u2013D361","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"11585_CR49","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R (2020) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36(8):2628\u20132629","journal-title":"Bioinformatics"},{"key":"11585_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lddd.2025.100149","author":"K Gupta","year":"2025","unstructured":"Gupta K et al (2025) Exploring the antimicrobial and biofilm inhibitory potential of Citrus limetta peel essential oil against multidrug-resistant Shigella: in vitro and in silico insights. Lett Drug Des Discov. https:\/\/doi.org\/10.1016\/j.lddd.2025.100149","journal-title":"Lett Drug Des Discov"},{"key":"11585_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101646","volume":"35","author":"DC Hall Jr.","year":"2020","unstructured":"Hall DC Jr., Ji HF (2020) A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease. Travel Med Infect Dis 35:101646","journal-title":"Travel Med Infect Dis"},{"key":"11585_CR52","doi-asserted-by":"crossref","unstructured":"Sahu, N., et al., Forecasting the Pharmacological Mechanisms of Plumbago zeylanica and Solanum xanthocarpum in Diabetic Retinopathy Treatment: A Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Study. Biology (Basel), 2024. 13(9).","DOI":"10.3390\/biology13090732"},{"key":"11585_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.879986","volume":"9","author":"S Tao","year":"2022","unstructured":"Tao S et al (2022) Anti-colon cancer effects of Dendrobium officinale Kimura & Migo revealed by network pharmacology integrated with molecular docking and metabolomics studies. Front Med (Lausanne) 9:879986","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"11585_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285965","volume":"18","author":"M Kandeel","year":"2023","unstructured":"Kandeel M et al (2023) Comprehensive in silico analyses of flavonoids elucidating the drug properties against kidney disease by targeting AIM2. PLoS ONE 18(5):e0285965","journal-title":"PLoS ONE"},{"issue":"2","key":"11585_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton GR et al (2012) Quantifying the chemical beauty of drugs. Nat Chem 4(2):90\u201398","journal-title":"Nat Chem"},{"key":"11585_CR56","doi-asserted-by":"crossref","unstructured":"Kosugi, T. and M. Ohue, Quantitative Estimate Index for Early-Stage Screening of Compounds Targeting Protein-Protein Interactions. Int J Mol Sci, 2021. 22(20).","DOI":"10.3390\/ijms222010925"},{"issue":"1","key":"11585_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13065-025-01386-5","volume":"19","author":"NH Metwally","year":"2025","unstructured":"Metwally NH et al (2025) Synthesis, antibacterial evaluation and in silico studies of novel 2-(benzo[d]thiazol-2-yl)-N-arylacetamides and their derivatives as potential DHFR inhibitors. BMC Chem 19(1):29","journal-title":"BMC Chem"},{"issue":"7","key":"11585_CR58","first-page":"7850","volume":"9","author":"R Rajan","year":"2024","unstructured":"Rajan R, Karthikeyan S, Desikan R (2024) Synthesis, structural elucidation, in silico and in vitro studies of new class of methylenedioxyphenyl-based amide derivatives as potential myeloperoxidase inhibitors for cardiovascular protection. ACS Omega 9(7):7850\u20137868","journal-title":"ACS Omega"},{"key":"11585_CR59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jep.2018.12.033","volume":"233","author":"B Li","year":"2019","unstructured":"Li B et al (2019) Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy. J Ethnopharmacol 233:158\u2013168","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"11585_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083922","volume":"8","author":"KY Hsin","year":"2013","unstructured":"Hsin KY, Ghosh S, Kitano H (2013) Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS ONE 8(12):e83922","journal-title":"PLoS ONE"},{"issue":"1","key":"11585_CR61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1158\/2159-8290.CD-16-0512","volume":"7","author":"C Saura","year":"2017","unstructured":"Saura C et al (2017) A first-in-human phase I study of the ATP-competitive AKT inhibitor Ipatasertib demonstrates robust and safe targeting of AKT in patients with solid tumors. Cancer Discov 7(1):102\u2013113","journal-title":"Cancer Discov"},{"issue":"2","key":"11585_CR62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/2159-8290.CD-17-1119","volume":"8","author":"RJ Sullivan","year":"2018","unstructured":"Sullivan RJ et al (2018) First-in-Class ERK1\/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study. Cancer Discov 8(2):184\u2013195","journal-title":"Cancer Discov"},{"issue":"45","key":"11585_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202400191","volume":"9","author":"Y Singh","year":"2024","unstructured":"Singh Y, Thareja S (2024) In silico molecular dynamics and 3D-QSAR study on thiazolidinedione derivatives as dual inhibitors of DPP IV and PTP1B (DDPI\u2019s) for the management of T2DM. ChemistrySelect 9(45):e202400191","journal-title":"ChemistrySelect"},{"issue":"12","key":"11585_CR64","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12(12):2032\u20132045","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"11585_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11892-019-1133-6","volume":"19","author":"B Thomas","year":"2019","unstructured":"Thomas B (2019) The global burden of diabetic kidney disease: time trends and gender gaps. Curr Diab Rep 19(4):18","journal-title":"Curr Diab Rep"},{"issue":"2","key":"11585_CR66","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.kint.2017.01.030","volume":"92","author":"CP Wen","year":"2017","unstructured":"Wen CP et al (2017) Diabetes with early kidney involvement may shorten life expectancy by 16 years. Kidney Int 92(2):388\u2013396","journal-title":"Kidney Int"},{"key":"11585_CR67","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720959962","volume":"11","author":"A Govindarajan Venguidesvarane","year":"2020","unstructured":"Govindarajan Venguidesvarane A et al (2020) Prevalence of vascular complications among Type 2 diabetic patients in a rural health center in South India. J Prim Care Community Health 11:2150132720959962","journal-title":"J Prim Care Community Health"},{"key":"11585_CR68","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fcell.2020.00187","volume":"8","author":"L Zhao","year":"2020","unstructured":"Zhao L, Zou Y, Liu F (2020) Transforming Growth Factor-Beta1 in diabetic kidney disease. Front Cell Dev Biol 8:187","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"11585_CR69","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00109-022-02204-4","volume":"100","author":"I Audzeyenka","year":"2022","unstructured":"Audzeyenka I et al (2022) PTEN-induced kinase 1 deficiency alters albumin permeability and insulin signaling in podocytes. J Mol Med (Berl) 100(6):903\u2013915","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"11585_CR70","first-page":"4490","volume":"17","author":"L Zhang","year":"2018","unstructured":"Zhang L et al (2018) PGC-1alpha ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism. Mol Med Rep 17(3):4490\u20134498","journal-title":"Mol Med Rep"},{"issue":"3","key":"11585_CR71","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2337\/db15-0473","volume":"65","author":"A Tagawa","year":"2016","unstructured":"Tagawa A et al (2016) Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy. Diabetes 65(3):755\u2013767","journal-title":"Diabetes"},{"issue":"1","key":"11585_CR72","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z et al (2024) Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther 9(1):234","journal-title":"Signal Transduct Target Ther"},{"key":"11585_CR73","doi-asserted-by":"crossref","unstructured":"Laghlam, D., M. Jozwiak, and L.S. Nguyen, Renin-Angiotensin-Aldosterone System and Immunomodulation: A State-of-the-Art Review. Cells, 2021. 10(7).","DOI":"10.3390\/cells10071767"},{"issue":"5","key":"11585_CR74","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","volume":"57","author":"MW Taal","year":"2000","unstructured":"Taal MW, Brenner BM (2000) Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int 57(5):1803\u20131817","journal-title":"Kidney Int"},{"issue":"1","key":"11585_CR75","first-page":"CD006763","volume":"1","author":"EM Hodson","year":"2023","unstructured":"Hodson EM, Cooper TE (2023) Altered dietary salt intake for preventing diabetic kidney disease and its progression. Cochrane Database Syst Rev 1(1):CD006763","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"11585_CR76","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12944-018-0791-8","volume":"17","author":"HG Zhu","year":"2018","unstructured":"Zhu HG et al (2018) Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials. Lipids Health Dis 17(1):141","journal-title":"Lipids Health Dis"},{"issue":"3","key":"11585_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.nutres.2010.03.002","volume":"30","author":"M Yokoyama","year":"2010","unstructured":"Yokoyama M et al (2010) Dietary polyunsaturated fatty acids slow the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Nutr Res 30(3):217\u2013225","journal-title":"Nutr Res"},{"key":"11585_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119159","volume":"339","author":"Y Duan","year":"2025","unstructured":"Duan Y et al (2025) A comprehensive pharmacokinetic strategy for systematic evaluation of whole interaction of different constituents in Astragali Radix - Fructus Corni to improve diabetic kidney disease. J Ethnopharmacol 339:119159","journal-title":"J Ethnopharmacol"},{"key":"11585_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.792777","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Quercetin attenuates podocyte apoptosis of diabetic nephropathy through targeting EGFR signaling. Front Pharmacol 12:792777","journal-title":"Front Pharmacol"},{"issue":"15","key":"11585_CR80","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1021\/acs.jafc.0c00680","volume":"68","author":"HX Zheng","year":"2020","unstructured":"Zheng HX et al (2020) Cyanidin-3-glucoside from black rice ameliorates diabetic nephropathy via reducing blood glucose, suppressing oxidative stress and inflammation, and regulating Transforming Growth Factor beta1\/Smad expression. J Agric Food Chem 68(15):4399\u20134410","journal-title":"J Agric Food Chem"},{"issue":"10","key":"11585_CR81","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00210-019-01777-1","volume":"393","author":"Y Xian","year":"2020","unstructured":"Xian Y et al (2020) Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice. Naunyn Schmiedebergs Arch Pharmacol 393(10):2009\u20132017","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"11585_CR82","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.2147\/DDDT.S171286","volume":"12","author":"N Du","year":"2018","unstructured":"Du N et al (2018) Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-beta1\/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy. Drug Des Devel Ther 12:3517\u20133524","journal-title":"Drug Des Devel Ther"},{"key":"11585_CR83","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.biopha.2018.03.037","volume":"102","author":"OJ Olatunji","year":"2018","unstructured":"Olatunji OJ, Chen H, Zhou Y (2018) Lycium chinense leaves extract ameliorates diabetic nephropathy by suppressing hyperglycemia mediated renal oxidative stress and inflammation. Biomed Pharmacother 102:1145\u20131151","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"11585_CR84","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/1440-1681.12402","volume":"42","author":"SF Sun","year":"2015","unstructured":"Sun SF et al (2015) Renoprotective effect of berberine on type 2 diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 42(6):662\u2013670","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"11585_CR85","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.biopha.2018.06.148","volume":"106","author":"AM Al Hroob","year":"2018","unstructured":"Al Hroob AM et al (2018) Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy. Biomed Pharmacother 106:381\u2013389","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"11585_CR86","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.nut.2008.12.007","volume":"25","author":"J Chiu","year":"2009","unstructured":"Chiu J et al (2009) Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 25(9):964\u2013972","journal-title":"Nutrition"},{"key":"11585_CR87","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1472-6882-13-251","volume":"13","author":"YS Kim","year":"2013","unstructured":"Kim YS et al (2013) Effects of Allium victorialis leaf extracts and its single compounds on aldose reductase, advanced glycation end products and TGF-beta1 expression in mesangial cells. BMC Complement Altern Med 13:251","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"11585_CR88","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/j.eclnm.2007.12.001","volume":"3","author":"K Al-Qattan","year":"2008","unstructured":"Al-Qattan K, Thomson M, Ali M (2008) Garlic (Allium sativum) and ginger (Zingiber officinale) attenuate structural nephropathy progression in streptozotocin-induced diabetic rats. e-SPEN Eur e-J Clin Nutr Metab 3(2):e62\u2013e71","journal-title":"e-SPEN Eur e-J Clin Nutr Metab"},{"issue":"2","key":"11585_CR89","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1161\/HYPERTENSIONAHA.110.153536","volume":"56","author":"V Kapil","year":"2010","unstructured":"Kapil V et al (2010) Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 56(2):274\u2013281","journal-title":"Hypertension"},{"issue":"3","key":"11585_CR90","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.107.103523","volume":"51","author":"AJ Webb","year":"2008","unstructured":"Webb AJ et al (2008) Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51(3):784\u2013790","journal-title":"Hypertension"},{"key":"11585_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/foods10092094","author":"PES Munekata","year":"2021","unstructured":"Munekata PES et al (2021) Beta vulgaris as a natural nitrate source for meat products: A review. Foods. https:\/\/doi.org\/10.3390\/foods10092094"},{"key":"11585_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60030394","author":"LN Al-Harbi","year":"2024","unstructured":"Al-Harbi LN et al (2024) Nephroprotective and anti-diabetic potential of Beta vulgaris L. root (beetroot) methanolic extract in a rat model of Type 2 diabetes mellitus. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina60030394","journal-title":"Medicina (Kaunas)"},{"key":"11585_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117856","volume":"255","author":"J Dhaliwal","year":"2020","unstructured":"Dhaliwal J et al (2020) Beneficial effects of ferulic acid alone and in combination with insulin in streptozotocin induced diabetic neuropathy in Sprague Dawley rats. Life Sci 255:117856","journal-title":"Life Sci"},{"issue":"10","key":"11585_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201900174","volume":"16","author":"X Cao","year":"2019","unstructured":"Cao X et al (2019) Caffeic acid inhibits the formation of advanced glycation end products (AGEs) and mitigates the AGEs-induced oxidative stress and inflammation reaction in human umbilical vein endothelial cells (HUVECs). Chem Biodivers 16(10):e1900174","journal-title":"Chem Biodivers"},{"issue":"5","key":"11585_CR95","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/biof.1373","volume":"43","author":"L Toma","year":"2017","unstructured":"Toma L et al (2017) Caffeic acid attenuates the inflammatory stress induced by glycated LDL in human endothelial cells by mechanisms involving inhibition of AGE-receptor, oxidative, and endoplasmic reticulum stress. BioFactors 43(5):685\u2013697","journal-title":"BioFactors"},{"key":"11585_CR96","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.lfs.2016.02.004","volume":"148","author":"HM Doss","year":"2016","unstructured":"Doss HM et al (2016) Targeting inflammatory mediators with ferulic acid, a dietary polyphenol, for the suppression of monosodium urate crystal-induced inflammation in rats. Life Sci 148:201\u2013210","journal-title":"Life Sci"},{"issue":"2","key":"11585_CR97","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12020-012-9868-8","volume":"44","author":"S Roy","year":"2013","unstructured":"Roy S et al (2013) Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic beta cell. Endocrine 44(2):369\u2013379","journal-title":"Endocrine"},{"issue":"1","key":"11585_CR98","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12986-021-00621-9","volume":"18","author":"N Abedimanesh","year":"2021","unstructured":"Abedimanesh N et al (2021) The anti-diabetic effects of betanin in streptozotocin-induced diabetic rats through modulating AMPK\/SIRT1\/NF-kappaB signaling pathway. Nutr Metab (Lond) 18(1):92","journal-title":"Nutr Metab (Lond)"},{"issue":"10","key":"11585_CR99","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1007\/s11033-022-07781-8","volume":"49","author":"M Mousavi","year":"2022","unstructured":"Mousavi M et al (2022) Betanin alleviates oxidative stress through the Nrf2 signaling pathway in the liver of STZ-induced diabetic rats. Mol Biol Rep 49(10):9345\u20139354","journal-title":"Mol Biol Rep"},{"issue":"10","key":"11585_CR100","first-page":"1188","volume":"26","author":"H Iskender","year":"2023","unstructured":"Iskender H et al (2023) Effects of oleanolic acid administration on renal NF-kB, IL-18, IL-6, YKL-40, and KIM-1 in experimental diabetic rats. Iran J Basic Med Sci 26(10):1188\u20131193","journal-title":"Iran J Basic Med Sci"},{"key":"11585_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25071609","author":"P Kashyap","year":"2020","unstructured":"Kashyap P et al (2020) Ajmalicine and reserpine: Indole alkaloids as multi-target directed ligands towards factors implicated in Alzheimer\u2019s Disease. Molecules. https:\/\/doi.org\/10.3390\/molecules25071609","journal-title":"Molecules"},{"issue":"3","key":"11585_CR102","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/ndt\/gfv377","volume":"31","author":"ES Lee","year":"2016","unstructured":"Lee ES et al (2016) Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model. Nephrol Dial Transplant 31(3):391\u2013400","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"11585_CR103","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0976-500X.107678","volume":"4","author":"VK Dubey","year":"2013","unstructured":"Dubey VK et al (2013) Oleanolic acid prevents progression of streptozotocin induced diabetic nephropathy and protects renal microstructures in Sprague Dawley rats. J Pharmacol Pharmacother 4(1):47\u201352","journal-title":"J Pharmacol Pharmacother"},{"issue":"11","key":"11585_CR104","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1139\/Y07-098","volume":"85","author":"D Gao","year":"2007","unstructured":"Gao D et al (2007) Antidiabetic potential of oleanolic acid from Ligustrum lucidum Ait. Can J Physiol Pharmacol 85(11):1076\u20131083","journal-title":"Can J Physiol Pharmacol"},{"key":"11585_CR105","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/973287","volume":"2015","author":"X Wang","year":"2015","unstructured":"Wang X et al (2015) Combination therapy with oleanolic acid and metformin as a synergistic treatment for diabetes. J Diabetes Res 2015:973287","journal-title":"J Diabetes Res"},{"issue":"2","key":"11585_CR106","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.taap.2014.03.016","volume":"277","author":"Y Li","year":"2014","unstructured":"Li Y et al (2014) Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1\/phosphatidylinositol 3-kinase\/Akt signaling pathway in rats. Toxicol Appl Pharmacol 277(2):155\u2013163","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"11585_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042115","volume":"7","author":"XY Zeng","year":"2012","unstructured":"Zeng XY et al (2012) Oleanolic acid reduces hyperglycemia beyond treatment period with Akt\/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice. PLoS ONE 7(7):e42115","journal-title":"PLoS ONE"},{"issue":"Pt 1","key":"11585_CR108","first-page":"1","volume":"636","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease. Biochem Biophys Res Commun 636(Pt 1):1\u20139","journal-title":"Biochem Biophys Res Commun"},{"key":"11585_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113424","volume":"153","author":"R Ma","year":"2022","unstructured":"Ma R et al (2022) Ferulic acid ameliorates renal injury via improving autophagy to inhibit inflammation in diabetic nephropathy mice. Biomed Pharmacother 153:113424","journal-title":"Biomed Pharmacother"},{"key":"11585_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00027","volume":"10","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S et al (2019) Ferulic acid protects hyperglycemia-induced kidney damage by regulating oxidative insult, inflammation and autophagy. Front Pharmacol 10:27","journal-title":"Front Pharmacol"},{"issue":"1","key":"11585_CR111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.diabres.2007.08.009","volume":"79","author":"A Fujita","year":"2008","unstructured":"Fujita A et al (2008) Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats. Diabetes Res Clin Pract 79(1):11\u201317","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"11585_CR112","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1038\/s41598-017-02320-z","volume":"7","author":"M Matboli","year":"2017","unstructured":"Matboli M et al (2017) Caffeic Acid Attenuates Diabetic Kidney Disease via Modulation of Autophagy in a High-Fat Diet\/Streptozotocin- Induced Diabetic Rat. Sci Rep 7(1):2263","journal-title":"Sci Rep"},{"issue":"3","key":"11585_CR113","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/mnfr.200900087","volume":"54","author":"CY Chao","year":"2010","unstructured":"Chao CY et al (2010) Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res 54(3):388\u2013395","journal-title":"Mol Nutr Food Res"},{"issue":"12","key":"11585_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201900405","volume":"16","author":"M Fathalipour","year":"2019","unstructured":"Fathalipour M et al (2019) Caffeic acid alkyl amide derivatives ameliorate oxidative stress and modulate ERK1\/2 and AKT signaling pathways in a rat model of diabetic retinopathy. Chem Biodivers 16(12):e1900405","journal-title":"Chem Biodivers"},{"issue":"11","key":"11585_CR115","first-page":"20330","volume":"8","author":"J Zhang","year":"2015","unstructured":"Zhang J et al (2015) KLF15 suppresses cell proliferation and extracellular matrix expression in mesangial cells under high glucose. Int J Clin Exp Med 8(11):20330\u201320336","journal-title":"Int J Clin Exp Med"},{"issue":"1\u20132","key":"11585_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-016-2722-1","volume":"419","author":"Z Hong","year":"2016","unstructured":"Hong Z et al (2016) Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model. Mol Cell Biochem 419(1\u20132):1\u20139","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"11585_CR117","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jcmm.12175","volume":"18","author":"Y Pan","year":"2014","unstructured":"Pan Y et al (2014) Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy. J Cell Mol Med 18(2):231\u2013241","journal-title":"J Cell Mol Med"},{"issue":"2","key":"11585_CR118","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.3390\/ijms14022242","volume":"14","author":"L Yu","year":"2013","unstructured":"Yu L et al (2013) Advanced Glycation End Product (AGE)-AGE Receptor (RAGE) System Upregulated Connexin43 Expression in Rat Cardiomyocytes via PKC and Erk MAPK Pathways. Int J Mol Sci 14(2):2242\u20132257","journal-title":"Int J Mol Sci"},{"issue":"8","key":"11585_CR119","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","volume":"106","author":"P Geraldes","year":"2010","unstructured":"Geraldes P, King GL (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106(8):1319\u20131331","journal-title":"Circ Res"},{"issue":"12","key":"11585_CR120","doi-asserted-by":"publisher","first-page":"F1569","DOI":"10.1152\/ajprenal.00560.2011","volume":"302","author":"HL Rui","year":"2012","unstructured":"Rui HL et al (2012) JNK-dependent AP-1 activation is required for aristolochic acid-induced TGF-beta1 synthesis in human renal proximal epithelial cells. Am J Physiol Renal Physiol 302(12):F1569\u2013F1575","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"11585_CR121","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4049\/jimmunol.176.1.603","volume":"176","author":"KY Lee","year":"2006","unstructured":"Lee KY et al (2006) NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. J Immunol 176(1):603\u2013615","journal-title":"J Immunol"},{"issue":"2","key":"11585_CR122","doi-asserted-by":"publisher","first-page":"F278","DOI":"10.1152\/ajprenal.00139.2003","volume":"286","author":"T Naito","year":"2004","unstructured":"Naito T et al (2004) Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol 286(2):F278\u2013F287","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"11585_CR123","doi-asserted-by":"publisher","first-page":"F495","DOI":"10.1152\/ajprenal.2001.280.3.F495","volume":"280","author":"BY Chin","year":"2001","unstructured":"Chin BY et al (2001) Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway. Am J Physiol Renal Physiol 280(3):F495-504","journal-title":"Am J Physiol Renal Physiol"},{"key":"11585_CR124","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2147\/DDDT.S310882","volume":"15","author":"L Lei","year":"2021","unstructured":"Lei L et al (2021) Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K\/Akt\/NF-kappaB Signaling Pathways. Drug Des Devel Ther 15:3131\u20133150","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"11585_CR125","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00109-009-0575-8","volume":"88","author":"TS Ha","year":"2010","unstructured":"Ha TS (2010) High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K\/Akt signaling. J Mol Med (Berl) 88(4):391\u2013400","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"11585_CR126","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/jcb.25881","volume":"118","author":"F Li","year":"2017","unstructured":"Li F et al (2017) Src Homology 2 Domain-Containing Inositol 5\u2019-Phosphatase ameliorates high glucose-induced extracellular matrix deposition via the Phosphatidylinositol 3-Kinase\/Protein Kinase B pathway in renal tubular epithelial cells. J Cell Biochem 118(8):2271\u20132284","journal-title":"J Cell Biochem"},{"issue":"4","key":"11585_CR127","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1074\/jbc.M310412200","volume":"279","author":"CE Runyan","year":"2004","unstructured":"Runyan CE, Schnaper HW, Poncelet AC (2004) The phosphatidylinositol 3-kinase\/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 279(4):2632\u20132639","journal-title":"J Biol Chem"},{"issue":"16","key":"11585_CR128","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1021\/acsomega.0c00356","volume":"5","author":"D Gupta","year":"2020","unstructured":"Gupta D et al (2020) Structure-based screening of non-beta-Lactam inhibitors against Class D beta-Lactamases: an approach of docking and molecular dynamics. ACS Omega 5(16):9356\u20139365","journal-title":"ACS Omega"},{"issue":"Pt 1(Pt 1)","key":"11585_CR129","first-page":"1","volume":"350","author":"MA Lemmon","year":"2000","unstructured":"Lemmon MA, Ferguson KM (2000) Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J 350(Pt 1(Pt 1)):1\u201318","journal-title":"Biochem J"},{"issue":"18","key":"11585_CR130","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1093\/emboj\/17.18.5374","volume":"17","author":"SJ Isakoff","year":"1998","unstructured":"Isakoff SJ et al (1998) Identification and analysis of PH domain-containing targets of phosphatidylinositol 3-kinase using a novel in vivo assay in yeast. EMBO J 17(18):5374\u20135387","journal-title":"EMBO J"},{"issue":"2","key":"11585_CR131","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tibs.2010.09.006","volume":"36","author":"SS Taylor","year":"2011","unstructured":"Taylor SS, Kornev AP (2011) Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci 36(2):65\u201377","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"11585_CR132","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nchembio.452","volume":"6","author":"LR Masterson","year":"2010","unstructured":"Masterson LR et al (2010) Dynamics connect substrate recognition to catalysis in protein kinase A. Nat Chem Biol 6(11):821\u2013828","journal-title":"Nat Chem Biol"},{"issue":"1","key":"11585_CR133","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/jm501603h","volume":"58","author":"RS Vijayan","year":"2015","unstructured":"Vijayan RS et al (2015) Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors. J Med Chem 58(1):466\u2013479","journal-title":"J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11585-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11585-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11585-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:02:46Z","timestamp":1791126166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11585-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":133,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11585"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11585-4","relation":{"references":[{"id-type":"doi","id":"10.3390\/foods10092094","asserted-by":"subject"}]},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}